In light of the NOAH-AFNET6 and ARTESiA trials, how would you approach the decision regarding anticoagulation for patients with incidentally-detected AF <24 hrs on pacemakers/defibrillators?
How would you balance the stroke risk against the bleeding risk? And how would the AF burden play into your decision- would you treat 6 minutes of AF the same as someone with 20 hours of AF?
Community PollStarted
In light of the NOAH-AFNET6 and ARTESiA trials, how would you approach anticoagulation for patients with incidentally-detected AF <24 hrs on pacemakers/defibrillators?
24 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Cardiology · Baylor College of Medicine/ Texas Children's Hospital
Answered on
Finding the right answer for subclinical atrial fibrillation is sometimes hard to tease out the subtleties. The 2023 ACC/AHA/HRS atrial fibrillation guidelines were published in Jan 2024 (Joglar et al., PMID 38033089) and a section (6.4.1) is dedicated to patients with CIED without prior atrial fibr...
Join for free or sign in to see the full answer